Chemically modified bovine -lactoglobulin as a broad-spectrum influenza virus entry inhibitor with the potential to combat influenza outbreaks

HIGHLIGHTS

• who: Yuhong Fu and colleagues from the Shanghai Public Health Clinical Center, Fudan University, Dong An Rd, Xuhui District, Shanghai, China have published the article: Chemically Modified Bovine -Lactoglobulin as a Broad-Spectrum Influenza Virus Entry Inhibitor with the Potential to Combat Influenza Outbreaks, in the Journal: Viruses 2022, 2055 of 30/07/2022
• what: The authors show its efficacy in potently inhibiting infection by divergent A and B Mechanistic studies suggest that 3HP-u03b2LG binds possibly through its negatively charged residues to the receptor-binding domain in the hemagglutinin 1 (HA1) subunit in the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.